Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy

Publisher： Karger

E-ISSN： 1660-3818|44|5|327-336

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.44, Iss.5, 2017-09, pp. : 327-336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mouse and human FcR effector functions

By  

IMMUNOLOGICAL REVIEWS (ELECTRONIC), Vol. 268, Iss. 1, 2015-11 ,pp. : 25-51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome

By  

Current Signal Transduction Therapy, Vol. 7, Iss. 3, 2012-09 ,pp. : 265-288

Bentham Science Publishers

Access to resources Recommend Favorite

Trastuzumab Single-Drug Therapy after Failure of Cytotoxic Treatment for Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 8-9, 2010-07 ,pp. : 425-430

Karger

Access to resources Recommend Favorite

The role of Fc receptors in HIV prevention and therapy

By  

IMMUNOLOGICAL REVIEWS (ELECTRONIC), Vol. 268, Iss. 1, 2015-11 ,pp. : 296-310

John Wiley & Sons Inc

Access to resources Recommend Favorite

Wnt5a as an Effector of TGFβ in Mammary Development and Cancer

By Serra Rosa  

Journal of Mammary Gland Biology and Neoplasia, Vol. 16, Iss. 2, 2011-06 ,pp. : 157-167

Springer Publishing Company

Access to resources Recommend Favorite